Table 1.
Clinical characteristics of patients in the whole population and according to the presence (FESC <60 μS) or absence of sudomotor dysfunction (FESC ≥60 μS).
| Parameters | Whole population (n = 50) | FESC < 60 µS (n = 13) | FESC ≥ 60 µS (n = 37) | p |
|---|---|---|---|---|
| Age (years) | 40.6 ± 13.3 | 53.5 ± 12.5 | 36.0 ± 10.3 | 0.0001 |
| BMI (kg/m2) | 25.8 ± 3.6 | 24.9 ± 2.8 | 26.1 ± 3.8 | 0.29 |
| Female n, % | 16 (32) | 5 (38) | 11 (30) | 0.56 |
| SBP (mm Hg) | 122.6 ± 7.8 | 123.5 ± 8.1 | 122.2 ± 7.8 | 0.60 |
| DBP (mm Hg) | 78.7 ± 5.4 | 78.7 ± 4.4 | 78.7 ± 5.7 | 0.96 |
| Heart rate (bpm) | 87.7 ± 13.2 | 96.2 ± 12.7 | 84.8 ± 12.2 | 0.0061 |
| HESC (µS) | 71.2 ± 13.2 | 58.2 ± 16.8 | 75.7 ± 7.9 | 0.0001 |
| Treated at home n, % | 16 (32) | 8 (62) | 8 (22) | 0.008 |
| Treated in hospital n, % | 34 (68) | 5 (38) | 29 (78) | |
| Antiviral treatment n % | 30 (60) | 13 (100) | 17 (46) | 0.0006 |
| Remdesivir n, % | 6 (12) | 4 (67) & | 2 (33) & | 0.01 |
| Other antiviral n, % | 24 (48) | 9 (69) & | 15 (41) & | 0.07 |
| At least one motor symptom | (48) 24 | (92) 12 | (32) 12 | 0.0002 |
| At least one sensory symptom | (78) 39 | (100) 13 | (70) 26 | 0.02 |
| At least one autonomic symptom | (82) 41 | (100) 13 | (76) 28 | 0.04 |
&: percentages calculated only from patients having received remdesivir or another antiviral treatment.